{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:49:17Z","timestamp":1791978557838,"version":"4.4.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F32DK124960"],"award-info":[{"award-number":["F32DK124960"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK114091"],"award-info":[{"award-number":["R01DK114091"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.berh.2021.101717","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T01:42:23Z","timestamp":1634866943000},"page":"101717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Urate transport in health and disease"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-7931","authenticated-orcid":false,"given":"Victoria L.","family":"Halperin Kuhns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-2180","authenticated-orcid":false,"given":"Owen M.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1203\/00006450-198807000-00163","article-title":"139 the solubility of uric acid and monosodium urate in urine","volume":"24","author":"Shimizu","year":"1988","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF02474201","article-title":"Solubility of uric acid and monosodium urate","volume":"10","author":"Wilcox","year":"1972","journal-title":"Med Biol Eng"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0305-0491(85)90381-5","article-title":"On the loss of uricolytic activity during primate evolution--I. Silencing of urate oxidase in a hominoid ancestor","volume":"81","author":"Friedman","year":"1985","journal-title":"Comp Biochem Physiol B"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.molbev.a004123","article-title":"Loss of urate oxidase activity in hominoids and its evolutionary implications","volume":"19","author":"Oda","year":"2002","journal-title":"Mol Biol Evol"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib5","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib6","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1073\/pnas.91.2.742","article-title":"Hyperuricemia and urate nephropathy in urate oxidase-deficient mice","volume":"91","author":"Wu","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.berh.2021.101717_bib7","series-title":"Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey 2007\u20132016","author":"Chen-Xu","year":"2019"},{"issue":"11","key":"10.1016\/j.berh.2021.101717_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11926-010-0094-1","article-title":"Uric acid and hypertension: cause or effect?","volume":"12","author":"Mazzali","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-020-02357-y","article-title":"Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load: an experimental intervention study in healthy volunteers","volume":"22","author":"Dalbeth","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2021.101717_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev Physiol"},{"issue":"18","key":"10.1016\/j.berh.2021.101717_bib12","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1111\/j.1742-4658.2011.08171.x","article-title":"ABCG transporters and disease","volume":"278","author":"Woodward","year":"2011","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib13","first-page":"1645","article-title":"Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes","volume":"20","author":"Zhang","year":"2019","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004390000243","article-title":"Segregation analysis of serum uric acid in the NHLBI Family Heart Study","volume":"106","author":"Wilk","year":"2000","journal-title":"Hum Genet"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib15","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1681\/ASN.2007040426","article-title":"Genome scan for determinants of serum uric acid variability","volume":"18","author":"Nath","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6887","key":"10.1016\/j.berh.2021.101717_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00207.2007","article-title":"Multiple organic anion transporters contribute to net renal excretion of uric acid","volume":"33","author":"Eraly","year":"2008","journal-title":"Physiol Genom"},{"issue":"59","key":"10.1016\/j.berh.2021.101717_bib18","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.18632\/oncotarget.20135","article-title":"Recent advances on uric acid transporters","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv Chron Kidney Dis"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.ajkd.2010.05.018","article-title":"Genome-wide association studies in nephrology research","volume":"56","author":"Kottgen","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"9654","key":"10.1016\/j.berh.2021.101717_bib21","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study","volume":"372","author":"Dehghan","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.berh.2021.101717_bib22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","article-title":"Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels","volume":"51","author":"Tin","year":"2019","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ng.106","article-title":"SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout","volume":"40","author":"Vitart","year":"2008","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000504","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations","volume":"5","author":"Kolz","year":"2009","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"Kottgen","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib26","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/annrheumdis-2016-209632","article-title":"GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes","volume":"76","author":"Nakayama","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2021.101717_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s42003-019-0339-0","article-title":"Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals","volume":"2","author":"Nakatochi","year":"2019","journal-title":"Commun Biol"},{"issue":"9","key":"10.1016\/j.berh.2021.101717_bib28","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/rheumatology\/kez685","article-title":"Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus","volume":"59","author":"Zaidi","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/hmg\/ddaa013","article-title":"Genomic dissection of 43 serum urate-associated loci provides multiple insights into molecular mechanisms of urate control","volume":"29","author":"Boocock","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ckj\/sfw010","article-title":"Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling","volume":"9","author":"Bhatnagar","year":"2016","journal-title":"Clin Kidney J"},{"issue":"7","key":"10.1016\/j.berh.2021.101717_bib31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.40110","article-title":"Population-specific resequencing associates the ATP-binding cassette subfamily C member 4 gene with gout in New Zealand maori and pacific men","volume":"69","author":"Tanner","year":"2017","journal-title":"Arthritis Rheum"},{"issue":"25","key":"10.1016\/j.berh.2021.101717_bib32","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-2836(02)00816-1","article-title":"Hepatocyte nuclear factor 1 alpha controls renal expression of the Npt1-Npt4 anionic transporter locus","volume":"322","author":"Cheret","year":"2002","journal-title":"J\u00a0Mol Biol"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/mol.106.025494","article-title":"Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha\/beta and DNA methylation","volume":"70","author":"Kikuchi","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/jpet.107.128249","article-title":"Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha\/beta","volume":"324","author":"Saji","year":"2008","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/jpet.111.187161","article-title":"Regulation of tissue-specific expression of renal organic anion transporters by hepatocyte nuclear factor 1 alpha\/beta and DNA methylation","volume":"340","author":"Jin","year":"2012","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"9","key":"10.1016\/j.berh.2021.101717_bib37","doi-asserted-by":"crossref","first-page":"F1041","DOI":"10.1152\/ajprenal.00640.2013","article-title":"Transcriptional regulation of urate transportosome member SLC2A9 by nuclear receptor HNF4alpha","volume":"307","author":"Prestin","year":"2014","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib38","doi-asserted-by":"crossref","first-page":"F973","DOI":"10.1152\/ajprenal.00650.2016","article-title":"Regulation of PDZ domain-containing 1 (PDZK1) expression by hepatocyte nuclear factor-1alpha (HNF1alpha) in human kidney","volume":"313","author":"Prestin","year":"2017","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s10038-020-0821-z","article-title":"Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects","volume":"66","author":"Takei","year":"2021","journal-title":"J\u00a0Hum Genet"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib40","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1038\/s41467-018-06620-4","article-title":"Large-scale whole-exome sequencing association studies identify rare functional variants influencing serum urate levels","volume":"9","author":"Tin","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib41","first-page":"44","article-title":"Hypouricemia and tubular transport of uric acid","volume":"31","author":"Esparza Martin","year":"2011","journal-title":"Nefrologia"},{"issue":"5 Pt 2","key":"10.1016\/j.berh.2021.101717_bib42","first-page":"F797","article-title":"Urate transport in brush-border membrane of human kidney","volume":"266","author":"Roch-Ramel","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.berh.2021.101717_bib43","first-page":"353","article-title":"A\u00a0three-component system for regulation of renal excretion of uric acid in man","volume":"74","author":"Gutman","year":"1961","journal-title":"Trans Assoc Am Phys"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib44","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0272-6386(98)70067-8","article-title":"Regulation of renal urate excretion: a critical review","volume":"32","author":"Maesaka","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"1\u20132","key":"10.1016\/j.berh.2021.101717_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000490573","article-title":"Dietary sodium intake and serum uric acid: a mini-review","volume":"6","author":"Lei","year":"2018","journal-title":"Pulse (Basel)."},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1172\/JCI107931","article-title":"The influence of the extracellular fluid volume on the tubular reabsorption of uric acid","volume":"55","author":"Weinman","year":"1975","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib47","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib48","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1681\/ASN.2006040415","article-title":"Human renal organic anion transporter 4 operates as an asymmetric urate transporter","volume":"18","author":"Hagos","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.berh.2021.101717_bib49","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1371\/journal.pmed.0050197","article-title":"SLC2A9 is a high-capacity urate transporter in humans","volume":"5","author":"Caulfield","year":"2008","journal-title":"PLoS Med"},{"issue":"2\u20133","key":"10.1016\/j.berh.2021.101717_bib50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Mol Aspect Med"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1681\/ASN.2020101406","article-title":"A comprehensive map of mRNAs and their isoforms across all 14 renal tubule segments of mouse","volume":"32","author":"Chen","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib52","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00424-018-2190-4","article-title":"SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney","volume":"470","author":"Auberson","year":"2018","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1523-1755.2003.00710.x","article-title":"Urate transport via human PAH transporter hOAT1 and its gene structure","volume":"63","author":"Ichida","year":"2003","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000074539","article-title":"Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux","volume":"13","author":"Bakhiya","year":"2003","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"10.1016\/j.berh.2021.101717_bib55","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/jps.23567","article-title":"Precise comparison of protein localization among OCT, OAT, and MATE in human kidney","volume":"102","author":"Motohashi","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.ki.5002645","article-title":"The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane","volume":"73","author":"Huls","year":"2008","journal-title":"Kidney Int"},{"issue":"34","key":"10.1016\/j.berh.2021.101717_bib57","doi-asserted-by":"crossref","first-page":"26107","DOI":"10.1074\/jbc.M110.122721","article-title":"Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter","volume":"285","author":"Iharada","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"45","key":"10.1016\/j.berh.2021.101717_bib58","doi-asserted-by":"crossref","first-page":"35123","DOI":"10.1074\/jbc.M110.121301","article-title":"Human sodium phosphate transporter 4 (hNPT4\/SLC17A3) as a common renal secretory pathway for drugs and urate","volume":"285","author":"Jutabha","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"16","key":"10.1016\/j.berh.2021.101717_bib59","doi-asserted-by":"crossref","first-page":"16229","DOI":"10.1074\/jbc.M312226200","article-title":"Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking","volume":"279","author":"Augustin","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116125","article-title":"The kidney transcriptome and proteome defined by transcriptomics and antibody-based profiling","volume":"9","author":"Habuka","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib61","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-020-16525-w","article-title":"The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion","volume":"11","author":"Hoque","year":"2020","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib62","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.stem.2018.10.010","article-title":"Comparative analysis and refinement of human PSC-derived kidney organoid differentiation with single-cell transcriptomics","volume":"23","author":"Wu","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015276","article-title":"Dynamic vs static ABCG2 inhibitors to sensitize drug resistant cancer cells","volume":"5","author":"Peng","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib64","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10157-015-1186-z","article-title":"Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2","volume":"20","author":"Mancikova","year":"2016","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib65","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/ndt\/gfr419","article-title":"Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2","volume":"27","author":"Dinour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.berh.2021.101717_bib66","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/molbev\/msw116","article-title":"Coevolution of URAT1 and uricase during primate evolution: implications for serum urate homeostasis and gout","volume":"33","author":"Tan","year":"2016","journal-title":"Mol Biol Evol"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib67","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.301.3.797","article-title":"Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors","volume":"301","author":"Enomoto","year":"2002","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib68","first-page":"E817","article-title":"Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity","volume":"274","author":"Stumvoll","year":"1998","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/cc1518","article-title":"Bench-to-bedside review: lactate and the kidney","volume":"6","author":"Bellomo","year":"2002","journal-title":"Crit Care"},{"issue":"Pt 3","key":"10.1016\/j.berh.2021.101717_bib70","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1113\/jphysiol.2004.063859","article-title":"The human tumor suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter","volume":"557","author":"Coady","year":"2004","journal-title":"J\u00a0Physiol"},{"issue":"11","key":"10.1016\/j.berh.2021.101717_bib71","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.bbamem.2007.06.031","article-title":"Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in the kidney","volume":"1768","author":"Gopal","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"37","key":"10.1016\/j.berh.2021.101717_bib72","doi-asserted-by":"crossref","first-page":"26769","DOI":"10.1074\/jbc.C600189200","article-title":"c\/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in the kidney","volume":"281","author":"Thangaraju","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib73","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1152\/ajplegacy.1970.219.4.1080","article-title":"Effect of phloridzin on uric acid excretion in man","volume":"219","author":"Skeith","year":"1970","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib74","doi-asserted-by":"crossref","first-page":"F173","DOI":"10.1152\/ajprenal.00462.2018","article-title":"SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1","volume":"316","author":"Novikov","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2\u20133","key":"10.1016\/j.berh.2021.101717_bib75","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mam.2012.12.001","article-title":"SLC13 family of Na(+)-coupled di- and tri-carboxylate\/sulfate transporters","volume":"34","author":"Bergeron","year":"2013","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.berh.2021.101717_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","volume":"80","author":"Borghi","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210487","article-title":"Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: a national study","volume":"14","author":"Mohammed","year":"2019","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.berh.2021.101717_bib78","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.berh.2021.101717_bib79","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib80","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"American college of rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060899","article-title":"Modulation of urate transport by drugs","volume":"13","author":"Tatrai","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.dmpk.2017.11.002","article-title":"Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2","volume":"33","author":"Nakamura","year":"2018","journal-title":"Drug Metabol Pharmacokinet"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib83","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/tpj.2015.101","article-title":"ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout","volume":"17","author":"Roberts","year":"2017","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib84","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cpt.89","article-title":"Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response","volume":"97","author":"Wen","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib85","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1124\/jpet.103.059139","article-title":"Interactions of human organic anion transporters with diuretics","volume":"308","author":"Hasannejad","year":"2004","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.berh.2021.101717_bib86","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fphar.2016.00518","article-title":"Identification of febuxostat as a new strong ABCG2 inhibitor: potential applications and risks in clinical situations","volume":"7","author":"Miyata","year":"2016","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.berh.2021.101717_bib87","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bdd.1909","article-title":"SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria","volume":"35","author":"Chino","year":"2014","journal-title":"Biopharm Drug Dispos"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib88","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1080\/13880209.2016.1195847","article-title":"Uric acid transporters hiding in the intestine","volume":"54","author":"Xu","year":"2016","journal-title":"Pharm Biol"},{"issue":"8","key":"10.1016\/j.berh.2021.101717_bib89","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.berh.2021.101717_bib90","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1038\/ncomms5642","article-title":"Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9","volume":"5","author":"DeBosch","year":"2014","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.berh.2021.101717_bib91","doi-asserted-by":"crossref","first-page":"C1652","DOI":"10.1152\/ajpcell.00015.2012","article-title":"A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter","volume":"302","author":"Togawa","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"issue":"24","key":"10.1016\/j.berh.2021.101717_bib92","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1074\/jbc.M800737200","article-title":"Identification of a new urate and high-affinity nicotinate transporter, hOAT10 (SLC22A13)","volume":"283","author":"Bahn","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s13577-013-0073-8","article-title":"Common missense variant of monocarboxylate transporter 9 (MCT9\/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility","volume":"26","author":"Nakayama","year":"2013","journal-title":"Hum Cell"},{"key":"10.1016\/j.berh.2021.101717_bib94","doi-asserted-by":"crossref","first-page":"31003","DOI":"10.1038\/srep31003","article-title":"Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2","volume":"6","author":"Matsuo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2021.101717_bib95","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.berh.2021.101717_bib96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physiol.00039.2004","article-title":"Molecular physiology of urate transport","volume":"20","author":"Hediger","year":"2005","journal-title":"Physiology"},{"key":"10.1016\/j.berh.2021.101717_bib97","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"issue":"48","key":"10.1016\/j.berh.2021.101717_bib98","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver","volume":"287","author":"Lanaspa","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.berh.2021.101717_bib99","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2337\/db12-1814","article-title":"Sugar, uric acid, and the etiology of diabetes and obesity","volume":"62","author":"Johnson","year":"2013","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.berh.2021.101717_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047948","article-title":"Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver","volume":"7","author":"Lanaspa","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.berh.2021.101717_bib101","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"36","key":"10.1016\/j.berh.2021.101717_bib102","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1073\/pnas.0904411106","article-title":"Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy","volume":"106","author":"Preitner","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030456","article-title":"Extra-renal elimination of uric acid via intestinal efflux transporter BCRP\/ABCG2","volume":"7","author":"Hosomi","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.berh.2021.101717_bib104","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.berh.2021.101717_bib105","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1800352","article-title":"Androgen and androgen receptor as enhancers of M2 macrophage polarization in allergic lung inflammation","volume":"201","author":"Becerra-Diaz","year":"2018","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11920-019-0993-4","article-title":"Links between stress, sleep, and inflammation: are there sex differences?","volume":"21","author":"Dolsen","year":"2019","journal-title":"Curr Psychiatr Rep"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib107","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/j.ajkd.2011.05.025","article-title":"Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis","volume":"58","author":"Costacou","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib108","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11892-018-0996-2","article-title":"Renal hyperfiltration in adolescents with type 2 diabetes: physiology, sex differences, and implications for diabetic kidney disease","volume":"18","author":"Bjornstad","year":"2018","journal-title":"Curr Diabetes Rep"},{"issue":"11","key":"10.1016\/j.berh.2021.101717_bib109","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2215\/CJN.04400419","article-title":"Sex differences in kidney replacement therapy initiation and maintenance","volume":"14","author":"Antlanger","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib110","doi-asserted-by":"crossref","first-page":"F456","DOI":"10.1152\/ajprenal.00249.2019","article-title":"Sex differences in diabetes and kidney disease: mechanisms and consequences","volume":"317","author":"Shepard","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib111","doi-asserted-by":"crossref","first-page":"F328","DOI":"10.1152\/ajprenal.00584.2018","article-title":"Recent advances in sex differences in kidney function","volume":"316","author":"Layton","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib112","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12891-017-1465-9","article-title":"Sex differences in gout characteristics: tailoring care for women and men","volume":"18","author":"Harrold","year":"2017","journal-title":"BMC Muscoskel Disord"},{"issue":"10","key":"10.1016\/j.berh.2021.101717_bib113","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/ard.2006.051649","article-title":"Sex differences in gout epidemiology: evaluation and treatment","volume":"65","author":"Harrold","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-018-1787-5","article-title":"Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank","volume":"21","author":"Narang","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124269","article-title":"Sex differences in urate handling","volume":"21","author":"Halperin Kuhns","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib116","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/hr.2013.134","article-title":"Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease","volume":"37","author":"Yoshitomi","year":"2014","journal-title":"Hypertens Res"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib117","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.116.08998","article-title":"Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study","volume":"69","author":"Kuwabara","year":"2017","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib118","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019535","article-title":"Sex-specific association of hyperuricemia with cardiometabolic abnormalities in a military cohort: the CHIEF study","volume":"99","author":"Lin","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib119","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/MAJ.0b013e3181db6e16","article-title":"Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population","volume":"339","author":"Chang","year":"2010","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/HJH.0000000000001908","article-title":"Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study","volume":"37","author":"Redon","year":"2019","journal-title":"J\u00a0Hypertens"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib121","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.diabet.2010.10.009","article-title":"Elevated serum uric acid predicts impaired fasting glucose and type 2 diabetes only among Japanese women undergoing health checkups","volume":"37","author":"Yamada","year":"2011","journal-title":"Diabetes Metab"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib122","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/0008-5472.CAN-03-3583","article-title":"Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene","volume":"64","author":"Ee","year":"2004","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib123","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/0008-5472.596.65.2","article-title":"Estrogen-mediated post-transcriptional down-regulation of breast cancer resistance protein\/ABCG2","volume":"65","author":"Imai","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib124","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002077R","article-title":"27-Hydroxycholesterol regulates human SLC22A12 gene expression through estrogen receptor action","volume":"35","author":"Matsubayashi","year":"2021","journal-title":"Faseb J"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib125","first-page":"3979","article-title":"Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene","volume":"117","author":"Selva","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.berh.2021.101717_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021667","article-title":"A\u00a0high-resolution genome-wide scan of HNF4alpha recognition sites infers a regulatory gene network in colon cancer","volume":"6","author":"Weltmeier","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.berh.2021.101717_bib127","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/ard.2009.109884","article-title":"Menopause, postmenopausal hormone use and risk of incident gout","volume":"69","author":"Hak","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib128","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.atherosclerosis.2012.10.044","article-title":"Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality","volume":"226","author":"Ioannou","year":"2013","journal-title":"Atherosclerosis"},{"issue":"9179","key":"10.1016\/j.berh.2021.101717_bib129","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(99)92381-4","article-title":"Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia","volume":"354","author":"Sumino","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib130","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","article-title":"Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney","volume":"59","author":"Cha","year":"2001","journal-title":"Mol Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.berh.2021.101717_bib131","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mam.2012.11.002","article-title":"Glucose transport families SLC5 and SLC50","volume":"34","author":"Wright","year":"2013","journal-title":"Mol Aspect Med"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib132","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1797.2010.01368.x","article-title":"Interactions of urate transporter URAT1 in human kidney with uricosuric drugs","volume":"16","author":"Shin","year":"2011","journal-title":"Nephrology"},{"issue":"40","key":"10.1016\/j.berh.2021.101717_bib133","doi-asserted-by":"crossref","first-page":"26834","DOI":"10.1074\/jbc.C800156200","article-title":"Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans","volume":"283","author":"Anzai","year":"2008","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib134","first-page":"186","article-title":"Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA","volume":"60","author":"Nindita","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.berh.2021.101717_bib135","doi-asserted-by":"crossref","first-page":"34995","DOI":"10.1038\/srep34995","article-title":"Mechanism of high affinity inhibition of the human urate transporter URAT1","volume":"6","author":"Tan","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib136","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40261-016-0386-y","article-title":"In Vitro and in vivo interaction studies between lesinurad, a selective urate reabsorption inhibitor, and major liver or kidney transporters","volume":"36","author":"Shen","year":"2016","journal-title":"Clin Drug Invest"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib137","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13075-016-1107-x","article-title":"Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney","volume":"18","author":"Miner","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2021.101717_bib138","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41598-017-00706-7","article-title":"Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout","volume":"7","author":"Tan","year":"2017","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"10.1016\/j.berh.2021.101717_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-019-01811-9","article-title":"Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia","volume":"24","author":"Kuriyama","year":"2020","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"10.1016\/j.berh.2021.101717_bib140","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/art.39687","article-title":"Editorial: pursuit of a dual-benefit antigout drug: a first look at arhalofenate","volume":"68","author":"Neogi","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.291","article-title":"Uricosuric targets of tranilast","volume":"5","author":"Mandal","year":"2017","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib142","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1124\/dmd.115.066795","article-title":"Solitary inhibition of the breast cancer resistance protein efflux transporter results in a clinically significant drug-drug interaction with rosuvastatin by causing up to a 2-fold increase in statin exposure","volume":"44","author":"Elsby","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib143","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.106.116517","article-title":"Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein","volume":"321","author":"Chu","year":"2007","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib144","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2169\/internalmedicine.49.2597","article-title":"Effect of fenofibrate on uric acid metabolism and urate transporter 1","volume":"49","author":"Uetake","year":"2010","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1211\/0022357055966","article-title":"Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7])","volume":"57","author":"Kobayashi","year":"2005","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.berh.2021.101717_bib146","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.berh.2019.03.010","article-title":"Management of complex gout in clinical practice: update on therapeutic approaches","volume":"32","author":"Narang","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2021.101717_bib147","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1681\/ASN.2007010106","article-title":"Torasemide transport by organic anion transporters contributes to hyperuricemia","volume":"18","author":"Hagos","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.berh.2021.101717_bib148","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.00528.2007","article-title":"Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics","volume":"294","author":"Vallon","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib149","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/bcp.13186","article-title":"In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin","volume":"83","author":"Mamidi","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib150","doi-asserted-by":"crossref","first-page":"e2347","DOI":"10.1210\/clinem\/dgaa748","article-title":"Dapagliflozin added to verinurad plus febuxostat further reduces serum uric acid in hyperuricemia: the QUARTZ study","volume":"106","author":"Stack","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.berh.2021.101717_bib151","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7150\/ijbs.33007","article-title":"Empagliflozin attenuates hyperuricemia by upregulation of ABCG2 via AMPK\/AKT\/CREB signaling pathway in type 2 diabetic mice","volume":"16","author":"Lu","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"2","key":"10.1016\/j.berh.2021.101717_bib152","doi-asserted-by":"crossref","first-page":"F386","DOI":"10.1152\/ajprenal.00503.2017","article-title":"Organic anion transporter OAT3 enhances the glucosuric effect of the SGLT2 inhibitor empagliflozin","volume":"315","author":"Fu","year":"2018","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"10.1016\/j.berh.2021.101717_bib153","first-page":"679","article-title":"Drug-induced hyperuricemia and gout","volume":"56","author":"Ben Salem","year":"2017","journal-title":"Rheumatology"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694221000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694221000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:21:43Z","timestamp":1761499303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694221000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1521694221000590"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2021.101717","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urate transport in health and disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2021.101717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101717"}}